4th- 6th April 2022 - TELOMERES and CANCER BIOLOGY conference
General Information
© dkfz.de
TELOMERES and CANCER BIOLOGY
conference
4th- 6th April 2022
- FOCUS 1: BASIC TELOMERE BIOLOGY
- FOCUS 2: COMPUTATIONAL TELOMERE ANALYSIS
- FOCUS 3: CLINICAL TRANSLATION
The conference schedule will explicitly address time-zone differences to maximize international inclusiveness.
Confirmed Speakers
- Roger Reddel (Children's Medical Research Institute, The University of Sydney)
- Anabelle Decottignies (Université catholique de Louvain)
- Rameen Beroukhim (Dana-Farber Cancer Institute/Harvard Medical School)
- Aurélie Ernst (German Cancer Research Center)
- Matthias Fischer (University Hospital Cologne)
- Rachel Flynn (Boston University School of Medicine)
- Stefan Fröhling (German Cancer Research Center)
- Christopher Heaphy (Boston University School of Medicine)
- Lilit Nersisyan (Armenian Bioinformatics Institute)
- John Maciejowski (Memorial Sloan Kettering Cancer Center)
- Priya Chudasama (German Cancer Research Center)
- Adam Wahida (Technische Universität München)
- Andrew Ludlow (University of Michigan)
Day 1 Overview
© dkfz.de
Day 2 Overview
© dkfz.de
Day 3 Overview
© dkfz.de
Registration
Link to "Registration and Abstract submission".
Description
The German Cancer Research Center (DKFZ) in Heidelberg will host a virtual conference on "Telomeres and Cancer Biology" on 4th-6th April 2022.
The interdisciplinary meeting will bring together basic biologists (FOCUS 1: BASIC TELOMERE BIOLOGY), computational scientists (FOCUS 2: COMPUTATIONAL TELOMERE ANALYSIS) and clinician scientists (FOCUS 3: CLINICAL TRANSLATION) to discuss recent discoveries in the field of replicative immortality and explore opportunities to translate them into improved patient health care.
The conference will cover the following specific research topics:
- Novel experimental methods for telomere analysis of tumor samples and model systems
- In silico analysis of telomeres from biomolecular data for diagnostic, prognostic and therapeutic purposes
- The implementation of telomere biomarkers into precision oncology workflows
- Advances in molecular targeting of telomere maintenance mechanisms
- Cancer subtype-specific characterization of replicative immortality by multi-omics approaches
- The impact of telomere crisis on genomic stability and cancer evolution
The conference schedule explicitly address time-zone differences to maximize international inclusiveness. For academic participants, the conference will be free of charge.
© dkfz.de
Board of Organizers
Hilda Pickett, PhD
Children's Medical Research Institute,
University of Sydney, Australia
Frank Westermann, MD
Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany
Division of Neuroblastoma Genomics, German Cancer Research Center (DKFZ), Heidelberg, Germany
Siyuan Zheng, PhD
Department of Health Population Sciences
Greehey Children's Cancer Research Institute
The University of Texas Health San Antonio, USA
Dennis Kappei, PhD
Cancer Science Institute of Singapore
National University of Singapore, Singapore
Lars Feuerbach, PhD
Comparative Cancer Genomics, Division of Applied Bioinformatics
German Cancer Research Center (DKFZ), Heidelberg, Germany
Administrative coordination:
Sabine Stainczyk, PhD
Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany
Division of Neuroblastoma Genomics, German Cancer Research Center (DKFZ), Heidelberg, Germany
IT-support:
Hans Bartelmeß, IT-Specialist
Division of Applied Bioinformatics / B330
Omics IT & Data Management Core Facility / W610
German Cancer Research Center (DKFZ), Heidelberg, Germany